Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...
A team of researchers at Glasgow Caledonian University have issued an update on the wearable headset device they are developing to help alert people about an impending epileptic seizure.
Ceribell’s LVO Stroke is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...
TipRanks on MSN
Ceribell wins FDA breakthrough status for LVO stroke tool
Ceribell, Inc. ( ($CBLL) ) has issued an announcement. On January 5, 2026, Ceribell announced that the U.S. Food and Drug Administration granted ...
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to ...
Trump's seizure of Maduro from Venezuela has shaken the global order and intensified concern that he will move on Greenland ...
Investing.com -- CeriBell, Inc. (NASDAQ:CBLL) stock jumped 8% on Monday after the medical technology company announced it received FDA Breakthrough Device Designation for its Large Vessel Occlusion ...
InvestorsHub on MSN
Ceribell shares advance after FDA grants breakthrough device status
CeriBell, Inc. (NASDAQ:CBLL) shares climbed 8% on Monday after the company said it had received Breakthrough Device ...
Rapid expansion led to overleveraging and rising defaults, forcing regulators to shift focus from growth to stability. The key takeaway is that unchecked lending can undermine both financial health ...
MulticoreWare, Inc., a global technology company and software partner for Qualcomm Incorporated, today announced a new ...
NEW research suggests electroencephalography may be arriving too late for many infants, as a study has found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback